FIELD: chemistry; pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutical chemistry and includes 5ʼ-O-acetoacetyl-2ʼ, 3ʼ-di-O-acetyluridine, a method for production thereof, method of treating the disorder, a pharmaceutical composition based thereon and intermediate compound 5ʼ-O-acetyluridine.
EFFECT: higher bioavailability of uridine for therapeutic purposes due to use of 5ʼ-O-acetoacetyl-2ʼ, 3ʼ-di-O-acetyluridine.
31 cl, 8 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND DEVICES FOR SYSTEMIC DELIVERY OF URIDINE | 2019 |
|
RU2832150C2 |
| COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR MODULATING DUX4 EXPRESSION | 2020 |
|
RU2831087C2 |
| THERAPEUTIC COMPOUNDS AND METHODS | 2018 |
|
RU2837261C2 |
| INHIBITORS - AMINO - CARBOXYMUCONATE - SEMIALDEHYDE - DECARBOXYLASE | 2015 |
|
RU2746405C2 |
| SUBSTITUTED CYANOPYRROLIDINES HAVING ACTIVITY OF USP30 INHIBITORS | 2020 |
|
RU2822680C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF MYOSITIS | 2020 |
|
RU2810508C2 |
| FORMED BY MEDIUM-CHAIN FATTY ACIDS ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL, AND COMPOSITIONS AND METHODS BASED ON THEM | 2017 |
|
RU2831011C1 |
| α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE INHIBITORS | 2019 |
|
RU2841136C2 |
| CHROMON OXIME NEW DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2015 |
|
RU2672569C2 |
| PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS | 2018 |
|
RU2804280C2 |
